HIF1A and neoplasm: The metformin-induced tumor growth delay and enhancement of the radiation-induced tumor growth delay may be attributable, at least in part, to the suppression of the HIF-1α/PD-L1 pathway and increase in T-cell-mediated anti-tumor immunity.